Form 4: Oric Pharmaceuticals Director Sells Shares
Insider Transaction (Form 4)
Richard A. Heyman, a Director of Oric Pharmaceuticals, Inc., sold 6,700 shares of common stock on October 1, 2026 for $12.91 per share.
Summary
- Option exercise/conversion: acquired 3,500 Common Stock at $1.60 ($5,600) on October 1, 2026; holds 41,800 after (Direct).
- Open-market sale: disposed of 3,500 Common Stock at $12.91 ($45,199) on October 1, 2026; holds 38,300 after (Direct).
- Open-market sale: disposed of 3,200 Common Stock at $12.91 ($41,325) on October 1, 2026; holds 203,472 after (Indirect).
- Option exercise/conversion: disposed of 3,500 Stock Option (right to buy) on October 1, 2026; holds 26,700 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $86,524 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Richard A. Heyman — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-01 | Option exercise/conversion | Common Stock | 3,500 | $2 | $5.6K | 41,800 |
| 2026-10-01 | Open-market sale | Common Stock | 3,500 | $13 | $45.2K | 38,300 |
| 2026-10-01 | Open-market sale | Common Stock | 3,200 | $13 | $41.3K | 203,472 |
| 2026-10-01 | Option exercise/conversion | Stock Option (right to buy) | 3,500 | — | — | 26,700 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-01 | Option exercise/conversion (3,500 shares) |
| 2026-10-01 | Open-market sale (3,500 shares) |
| 2026-10-01 | Open-market sale (3,200 shares) |
| 2026-10-01 | Option exercise/conversion (3,500 shares) |
Keywords
insider transaction, Form 4, ORIC, Oric Pharmaceuticals, Inc., bearish, Richard A. Heyman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.